Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway

Chronic lymphocytic leukemia (CLL) involves a profound humoral immune defect and tumor-specific humoral tolerance that directly contribute to disease morbidity and mortality. CD154 gene therapy can reverse this immune defect, but attempts to do this pharmacologically have been unsuccessful. The immu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lapalombella, Rosa, Andritsos, Leslie, Liu, Qing, May, Sarah E., Browning, Rebekah, Pham, Lan V., Blum, Kristie A., Blum, William, Ramanunni, Asha, Raymond, Chelsey A., Smith, Lisa L., Lehman, Amy, Mo, Xiaokui, Jarjoura, David, Chen, Ching-Shih, Ford, Richard, Rader, Christoph, Muthusamy, Natarajan, Johnson, Amy J., Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852364/
https://ncbi.nlm.nih.gov/pubmed/19965642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-09-242438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados